Browse > Article

The Inhibitory Activity of Polygonum Multiflorum Thunberg and its Effect on Postprandial Hyperglycemia in Streptozotocin-induced Diabetic Rats  

Kang Min-Jung (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Kim Jung-In (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Joo Hee-Jeong (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Seo Tae-Jin (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Kim Hyun-Ah (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Han Jung-Hee (Department of Nutrition, Pusan Paik Hospital)
Publication Information
Nutritional Sciences / v.8, no.4, 2005 , pp. 226-230 More about this Journal
Abstract
To keep blood glucose levels as close to normal as possible is the major goal of diabetes mellitus treatment $\alpha$-Glucosidase is the enzyme that digests die1my carbohydrate and inhibition of this enzyme may suppress postprandial hyperglycemia. The methanol extract of Polygonum multiflorum Thunberg was tested for inhibitoty activity against $\alpha$-glucosidase in vitro and in vivo. Polygonum multiflorum Thunberg extract inhibited yeast $\alpha$-glucosidase activity in a concentration-dependent manner. Polygonum multiflorum Thunberg showed an $IC_{50}$ value of 0.48 mg/mL. The ability of Polygonum multiflorum Thunberg extract to lower postprandial glucose was studied in streptozotocin-induced diabetic rats. A starch solution (1 g/kg) with and without the methanol extract of Polygonum multiflorum Thunberg extract (500 mg/kg) was administered to diabetic rats by gastric intubation after an overnight fast A single oral dose of Polygonum multiflorum Thunberg extract significantly inhibited increases in blood glucose levels at 60 and 90 min (p<0.05) and significantly decreased incremental response areas under the glycemic response curve (p<0.05). These results suggest that Polygonum multiflorum Thunberg may have an antihyperglycemic effect by inhibiting $\alpha$-glucosidase activity in the animal model of diabetes mellitus.
Keywords
Polygonum multiflorum Thunberg; Antihyperglycemic effect; Diabetes mellitus;
Citations & Related Records
연도 인용수 순위
  • Reference
1 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-31, 1998
2 The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in the diabetes control in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993   DOI   ScienceOn
3 Haller H. The clinical importance of postprandial glucose. Diabetes Res Clin Pract 40:S43-49, 1998   DOI   ScienceOn
4 Saito N, Sakai H, Sekihara H, Yajima Y. Effect of an ${\alpha}$-glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes subjects. J lnt Med Res 26:219-232, 1998
5 Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y, Oki T, Osajima Y. In vitro survey of ${\alpha}$-glucosidase inhibitory food components. Biosci Biotechnol Biochem 60:2019-2022, 1996   DOI   ScienceOn
6 Fujita H, Yamagami T, Ohshima K. Fermented soybean-derived touchi extract with anti-glycaemic effect via ${\alpha}$-glucosidase inhibitory action in rats and humans. J Nutr 131:1211-1213, 2001
7 Mooradian AD, Thurman JE. Drug therapy of postprandial hyperglycemia. Drugs 57:19-29, 1999
8 Baron AD. Postprandial hyperglycaemia and ${\alpha}$-glucosidase inhibitors. Diabetes Res Clin Pract 40:S51-55, 1998   DOI   ScienceOn
9 Korea National Statistical Office: The cause of death Statistics 2001. Annual Report of on the Cause of Death Statistics. Korea National Statistical Office, Seoul, Korea, 2002
10 UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317:703-713, 1998   DOI   ScienceOn
11 Youn JY, Park HY, Cho KH. Anti-hyperglycemic activity of Commelina communis L.: inhibition of ${\alpha}$-glucosidase. 66S:S149-155, 2004
12 Jenkins DJ, Wolever TM, Jenkins AL. Starchy foods and glycemic index. Diabetes Care 11:149-159, 1988   DOI   ScienceOn
13 Sels JP, Huijberts MS, Wolffenbuttel BH. Miglitol, a new alpha-glucosidase inhibitor. Espert Opin Pharmacother 1:149-156, 1999   DOI   ScienceOn
14 Centers for Disease Control and Prevention. Diabetes Surveillance Report, Atlanta, GA: US Department of Health and Human Services. 1999
15 Shim YJ, Doo HK, Ahn SY, Kim YS, Seong JK, Park IS, Min BH. Inhibitory effect of aqueous extract from the gall of Rhus Chinensis on alpha-glucosidase activity and postprandial blood glucose. J Ethnopharmacol 85:283-287, 2003   DOI   ScienceOn
16 Hanefeld M. The Role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complications 12:228-237, 1998   DOI   PUBMED   ScienceOn
17 Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD. Punica granatum flower extract, a potent ${\alpha}$-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol 99:239-244, 2005   DOI   ScienceOn
18 Mooradian AD, Jerome E. Drug therapy of postprandial hyperglycemia. Drugs 57:19-29, 1999
19 Lee SS, Lee SJ, Kim KH. Effect of Jiao Teng-Yuan on oxidation stress caused by D-galactose in Sprague-Dawley rats. J Korean Oriental Med 25:194-206, 2004
20 Watanabe J, Kawabata J, Kurihara H, Niki R. Isolation and identification of ${\alpha}$-glucosidase inhibitors from Tochu-cha (Encommia ulmoides). Biosci Biotechnol Biochem 61:177-178, 1997   DOI   ScienceOn
21 Nishioka T, Kawabata J, Aoyama Y. Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis. J Nat Prod 61:1413-1415, 1998   DOI   ScienceOn
22 WHO. Medicinal Plants in China 2nd ed. pp.229, 1997
23 Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826, 1997   DOI   ScienceOn
24 Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. Acarbose controls postprandial hyper-proinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Prac 36:143-151, 1997   DOI   ScienceOn
25 Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res Clin Pract 46:23-27, 1999   DOI   ScienceOn
26 Bastyr EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE. (IOEZ Study Group): Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care 23:1236-1241, 2000   DOI   ScienceOn
27 Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-827, 2001   DOI   PUBMED   ScienceOn
28 Stand E, Baumgartl HJ, Fuchtenbusch M, Stemplinger J. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1:215-220, 1999   DOI   ScienceOn
29 Mooradian AD, Thurman JE. Drug therapy of post-prandial hyperglycaemia. Drugs 57:19-29, 1999